Intellia (NTLA) is a publicly traded Healthcare sector company. As of May 20, 2026, NTLA trades at $12.35 with a market cap of $1.77B and a P/E ratio of -3.48. NTLA moved +2.68% today. Year to date, NTLA is +29.64%; over the trailing twelve months it is +31.79%. Its 52-week range spans $5.90 to $28.25. Analyst consensus is buy with an average price target of $21.06. Rallies surfaces NTLA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading NTLA stock inside the company?
Recent NTLA insider activity includes BASTA JAMES sold 1.21K, Clark Eliana sold 607, LEONARD JOHN M sold 34.15K, Schultes Birgit C sold 8.51K, and BASTA JAMES sold 10.40K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
NTLA Key Metrics
Key financial metrics for NTLA
Metric
Value
Price
$12.35
Market Cap
$1.77B
P/E Ratio
-3.48
EPS
$-3.53
Dividend Yield
0.00%
52-Week High
$28.25
52-Week Low
$5.90
Volume
3.64M
Avg Volume
0
Revenue (TTM)
$66.09M
Net Income
$-394.60M
Gross Margin
0.00%
Recent NTLA Insider Trades
BASTA JAMES sold 1.21K (~$16.69K) on Mar 2, 2026.
Clark Eliana sold 607 (~$8.36K) on Mar 2, 2026.
LEONARD JOHN M sold 34.15K (~$314.48K) on Jan 5, 2026.
Schultes Birgit C sold 8.51K (~$78.36K) on Jan 5, 2026.
BASTA JAMES sold 10.40K (~$95.76K) on Jan 5, 2026.
Recent NTLA insider activity includes BASTA JAMES sold 1.21K, Clark Eliana sold 607, LEONARD JOHN M sold 34.15K, Schultes Birgit C sold 8.51K, and BASTA JAMES sold 10.40K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for NTLA?
Yes. Rallies tracks NTLA insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is NTLA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NTLA. It does not provide personalized investment advice.
